AMRI-59 functions as a radiosensitizer via peroxiredoxin I-targeted ROS accumulation and apoptotic cell death induction
'Control', mock control; '10 μM' and '30 μM', treatment with 10 and 30 μM AMRI-59 only; '3 Gy' and '5 Gy', treatment with 3 and 5 Gy IR only, respectively; '3 Gy/10 μM', '3 Gy/30 μM' and '5 Gy/10 μM', '5 Gy/30 μM', combination with 3 or 5 Gy IR and 10 or 30 μM AMRI-59, respectively; 'z-VAD', 20 μM of z-VAD-fmk pre-treatment for 1 h. (A) PI uptake assay for detection of apoptosis. NCI-H460 or NCI-H1299 cells were treated with various doses of AMRI-59 and IR. (B) PI uptake assay with or without pre-treatment of z-VAD-fmk for 1 h combined with AMRI-59 and IR.
